Molecular basis of inherited microcytic anemia due to defects in iron acquisitionor heme synthesis

Haematologica

Volumn 94, Issue 3, 2009, Pages 395-408

  Lolascon, Achille ^a   De Falco, Luigia ^a   Beaumont, Carole ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

Author keywords

Anemia; Heme; Iron; Microcytosis; Red blood cells

Indexed keywords

ERYTHROPOIETIN; HEPCIDIN; IRON; IRON REGULATORY FACTOR; IRON SULFUR PROTEIN; MEMBRANE PROTEIN; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; PROTEIN KINASE PIM 1;

ALAS2 GENE; ANEMIA; CONGENITAL ERYTHROPOIETIC PORPHYRIA; ENDOSOME; ERYTHROCYTE; ERYTHROID CELL; ERYTHROPHAGOCYTOSIS; GENE; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC DISORDER; HEME SYNTHESIS; IRON METABOLISM DISORDER; MEMBRANE PROTEIN TMPRSS6; MICROCYTIC ANEMIA; MICROCYTOSIS; MITOCHONDRION; NONHUMAN; PORPHYRIA; RECYCLING; REVIEW; SIDEROBLASTIC ANEMIA; TRANSFERRIN DEFICIENCY; X LINKED SIDEROBLASTIC ANEMIA; X LINKED SIDEROBLASTIC ANEMIA WITH ATAXIA;

5-AMINOLEVULINATE SYNTHETASE; ANEMIA; ANEMIA, HYPOCHROMIC; ANEMIA, SIDEROBLASTIC; ANIMALS; HEME; HUMANS; IRON; MODELS, BIOLOGICAL; MUTATION;

EID: 63149128149     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.13619     Document Type: Review

References (124)

1. De Domenico I, McVey Ward D, Kaplan J. Regulation of iron acquisition and storage: consequences for iron-linked disorders. Nat Rev Mol Cell Biol 2008;9:72-81.
2. Coopersmith A, Ingram M. Red cell volumes and erythropoiesis. II. Age: density: volume relationships of macrocytes. Am J Physiol 1969;216: 473-82.
3. Ponka P, Beaumont C, Richardson DR. Function and regulation of transferrin and ferritin. Semin Hematol 1998;35:35-54.
4. Camaschella C. Understanding iron homeostasis through genetic analysis of hemochromatosis and related disorders. Blood 2005;106:3710-7.
5. Conner SD, Schmid SL. Differential requirements for AP-2 in clathrin- mediated endocytosis. J Cell Biol 2003;162:773-9.
6. Canonne-Hergaux F, Zhang AS, Ponka P, Gros P. Characterization of the iron transporter DMT1 (NRAMP2/DCT1) in red blood cells of normal and anemic mk/mk mice. Blood 2001;98: 3823-30.
7. Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, Boron WF, et al. Cloning and characterization of a mammalian proton-coupled metal- ion transporter. Nature 1997;388: 482-8.
8. Ohgami RS, Campagna DR, Greer EL, Antiochos B, McDonald A, Chen J, et al. Identification of a ferrireductase required for efficient transferrin- dependent iron uptake in erythroid cells. Nat Genet 2005;37:1264-9.
9. Ohgami RS, Campagna DR, Antiochos B, Wood EB, Sharp JJ, Barker JE, et al. nml054: a spontaneous, recessive, hypochromic, microcytic anemia mutation in the mouse. Blood 2005;106:3625-31.
10. Ohgami RS, Campagna DR, McDonald A, Fleming MD. The Steap proteins are metalloreductases. Blood 2006;108:1388-94.
11. Lim JE, Jin O, Bennett C, Morgan K, Wang F, Trenor CC 3rd, et al. A mutation in Secl511 causes anemia in hemoglobin deficit (hbd) mice. Nat Genet 2005;37:1270-3.
12. White RA, Boydston LA, Brookshier TR, McNulty SG, Nsumu NN, Brewer BP, et al. Iron metabolism mutant hbd mice have a deletion in Secl511, which has homology to a yeast gene for vesicle docking. Genomics 2005; 86:668-73.
13. TerBush DR, Novick P. Sec6, Sec8, and Secl5 are components of a multisub- unit complex which localizes to small bud tips in Saccharomyces cerevisiae. J Cell Biol 1995;130:299-312.
14. Zhang AS, Sheftel AD, Ponka P. The anemia of "haemoglobin- deficit" (hbd/hbd) mice is caused by a defect in transferrin cycling. Exp Hematol 2006;34:593-8.
15. Katz JH. Iron and protein kinetics studied by means of doubly labelled human crystalline transferrin. J Clin Invest 1961:2143-52.
16. Levy JE, Jin O, Fujiwara Y, Kuo F,Andrews NC. Transferrin receptor is necessary for development of erythrocytes and the nervous system. Nat Genet 1999;21:396-9.
17. Zhu BM, McLaughlin SK, Na R, Liu J, Cui Y, Martin C, et al. Hematopoietic- specific Stat5-null mice display micro cytic hypochromic anemia associated with reduced transferrin receptor gene expression. Blood 2008;112:2071-80.
18. Kerenyi MA, Grebien F, Gehart H, Schifrer M, Artaker M, Kovacic B, et al. Stat5 regulates cellular iron uptake of erythroid cells via IRP-2 and TfR-1. Blood 2008;112:3878-88.
19. Napier I Ponka P, Richardson DR. Iron trafficking in the mitochondrion: novel pathways revealed by disease. Blood 2005;105:1867-74.
20. Sheftel AD, Zhang AS, Brown C, Shirihai OS, Ponka P. Direct interor- ganellar transfer of iron from endo- some to mitochondrion. Blood 2007; 110:125-32.
21. Shaw GC, Cope JJ, Li L, Corson K, Hersey C, Ackermann GE, et al. Mito- ferrin is essential for erythroid iron assimilation. Nature 2006;440:96-100.
22. Muhlenhoff U, Stadler JA, Richhardt N, Seubert A, Eickhorst T, Schweyen RJ, et al. A specific role of the yeast mitochondrial carriers MRS3/4p in mitochondrial iron acquisition under iron-limiting conditions. J Biol Chem 2003;278:40612-20.
23. Ferreira GC, Gong J. 5-Amino- levulinate synthase and the first step of heme biosynthesis. J Bioenerg Biomembr 1995;27:151-9.
24. Shirihai OS, Gregory T, Yu C, Orkin SH, Weiss MJ. ABC-me: a novel mitochondrial transporter induced by GATA-1 during erythroid differentiation. EMBO J 2000;19:2492-502.
25. Krishnamurthy P, Ross DD, Nakanishi T, Bailey-Dell K, Zhou S, Mercer KE, et al. The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme. J Biol Chem 2004;279:24218- 25.
26. Lill R, Muhlenhoff U. Iron-sulfur protein biogenesis in eukaryotes: components and mechanisms. Annu Rev Cell Dev Biol Rev 2006;22:457-86.
27. Tailor CS, Willett BJ, Kabat D. A putative cell surface receptor for anemia- inducing feline leukemia virus subgroup C is a member of a transporter superfamily. J Virol 1999;73:6500-5.
28. Quigley JG, Yang Z, Worthington MT, Phillips JD, Sabo KM, SabathDE, etal. Identification of a human heme exporter that is essential for erythropoiesis. Cell 2004;118:757-66.
29. Keel SB, Doty RT, Yang Z, Quigley JG, Chen J, Knoblaugh S, et al. A heme export protein is required for red blood cell differentiation and iron homeostasis. Science 2008; 319:825-8.
30. Fontenay M, Cathelin S, Amiot M, Gyan E, Solary E. Mitochondria in hematopoiesis and hematological dis eases. Oncogene 2006;25:4757-67.
31. Martin FM, Bydlon G, Friedman JS. SOD2-deficiency sideroblastic anemia and red blood cell oxidative stress. Antioxid Redox Signal 2006;8:1217- 25.
32. Ponka P. Tissue-specific regulation ofiron metabolism and heme synthesis: distinct control mechanisms in erythroid cells. Blood 1997;89:1-25.
33. Muckenthaler MU, Galy B, Hentze MW. Systemic iron homeostasis and the Iron-responsive Element/iron- Regulatory Protein (IRE/IRP) Regulatory Network. Annu Rev Nutr 2008; 28:197-213.
34. Sposi NM, Cianetti L, Tritarelli E, Pelosi E, Militi S, Barberi T, et al. Mechanisms of differential transferrin receptor expression in normal hematopoiesis. Eur J Biochem 2000; 267: 6762-74.
35. Meyron-Holtz EG, Ghosh MC, Iwai K, LaVaute T, Brazzolotto X, Berger UV, et al. Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis. EMBO J 2004; 23:386-95.
36. Galy B, Ferring D, Minana B, Bell O, Janser HG, Muckenthaler M, et al. Altered body iron distribution and microcytosis in mice deficient in iron regulatory protein 2 (IRP2). Blood 2005;106:2580-9.
37. Cooperman SS, Meyron-Holtz EG, Olivierre-Wilson H, Ghosh MC, McConnellJP, RouaultTA. Microcytic anemia, erythropoietic protoporphyria, and neurodegeneration in mice with targeted deletion of iron-regulatory protein 2. Blood 2005;106:1084- 91.
38. Schranzhofer M, Schifrer M, Cabrera JA, Kopp S, Chiba P, Beug H, et al. Remodeling the regulation of iron metabolism during erythroid differentiation to ensure efficient heme biosynthesis. Blood 2006;107:4159- 67.
39. Reichard JF, Motz GT, Puga A. Heme oxygenase-1 induction by NRF2 requires inactivation of the transcriptional repressor BACH1. Nucleic Acids Res 2007;35:7074-86.
40. Iwasaki K, Mackenzie EL, Haile- mariam K, Sakamoto K, Tsuji Y. Hemin-mediated regulation of an antioxidant-responsive element of the human ferritin H gene and role of Ref- 1 during erythroid differentiation of K562 cells. Mol Cell Biol 2006;26: 2845-56.
41. Tahara T, Sun J, Nakanishi K, Yamamoto M, Mori H, Saito T, et al. Heme positively regulates the expression of pS-globin at the locus control region via the transcriptional factor Bachl in erythroid cells. J Biol Chem 2004;279:5480-7.
42. Fujita H, Yamamoto M, Yamagami T, Hayashi N, Bishop TR, De Verneuil H, et al. Sequential activation of genes for heme pathway enzymes during erythroid differentiation of mouse Friend virus-transformed ery- throleukemia cells. Biochim Biophys Acta 1991;1090:311-6.
43. Kramer G, Cimadevilla JM, Hardesty B. Specificity of the protein kinase activity associated with the hemin- controlled repressor of rabbit reticulocyte. Proc Natl Acad Sci USA 1976; 73:3078-82.
44. McEwen E, Kedersha N, Song B, Scheuner D, Gilks N, Han A, et al. Heme-regulated inhibitor kinase-mediated phosphorylation of eukary- otic translation initiation factor 2 inhibits translation, induces stress granule formation, and mediates survival upon arsenite exposure. J Biol Chem 2005;280:16925-33.
45. Han AP, Yu C, Lu L, Fujiwara Y, Browne C, Chin G, et al. Heme-regulated eIF2alpha kinase (HRI) is required for translational regulation and survival of erythroid precursors in iron deficiency. EMBO J 2001;20: 6909-18.
46. Ishikawa H, Kato M, Hori H, Ishimori K, Kirisako T, Tokunaga F, et al. Involvement of heme regulatory motif in heme-mediated ubiquitina- tion and degradation of IRP2. Mol Cell 2005;19:171-81.
47. Faller M, Matsunaga M, Yin S, Loo JA, Guo F. Heme is involved in microRNA processing. Nat Struct Mol Biol 2007;14:23-9.
48. Knutson M, Wessling-Resnick M. Iron metabolism in the reticuloendothelial system. Crit Rev Biochem Mol Biol 2003;38:61-88.
49. Lutz HU, Fasler S, Stammler P, Bussolino F, Arese P. Naturally occurring anti-band 3 antibodies and complement in phagocytosis of oxidative- ly-stressed and in clearance of senescent red cells. Blood Cells 1988;14: 175-203.
50. Bratosin D, Estaquier J, Petit F, Arnoult D, Quatannens B, Tissier JP, et al. Programmed cell death in mature erythrocytes: a model for investigating death effector pathways operating in the absence of mitochondria. Cell Death Differ 2001;8: 1143-56.
51. Desjardins M. ER-mediated phagocytosis: a new membrane for new functions. Nat Rev Immunol 2003;3:280- 91.
52. Furuyama K, Kaneko K, Vargas PD. Heme as a magnificent molecule with multiple missions: heme determines its own fate and governs cellular homeostasis. Tohoku J Exp Med 2007-213:1-16.
53. Delaby C, Pilard N, Puy H, Canonne- Hergaux F. Sequential regulation of ferroportin expression after erythrophagocytosis in murine macrophages: early mRNA induction by haem, followed by iron-dependent protein expression. Biochem J 2008; 411:123-31.
54. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, et at. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004;306:2090-3.
55. Delaby C, Pilard N, Goncalves AS, Beaumont C, Canonne-Hergaux F. Presence of the iron exporter ferro portin at the plasma membrane of macrophages is enhanced by iron loading and down-regulated by hepcidin. Blood 2005;106:3979-84.
56. Kempe DS, Lang PA, Duranton C, Akel A, Lang KS, Huber SM, et al. Enhanced programmed cell death of iron-deficient erythrocytes. FASEB J 2006;20:368-70.
57. Hebbel RP, Miller WJ. Phagocytosis of sickle erythrocytes: immunologicand oxidative determinants of hemolytic anemia. Blood 1984;64: 733-41.
58. Otogawa K, Kinoshita K, Fujii H, Sakabe M, Shiga R, Nakatani K, et al. Erythrophagocytosis by liver macrophages (Kupffer cells) promotes oxidative stress, inflammation, and fibrosis in a rabbit model of steato- hepatitis: implications for the pathogenesis of human nonalcoholic steatohepatitis. Am J Pathol 2007; 170:967-80.
59. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005; 352:1011-23.
60. Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001;276:7806-10.
61. Krause A, Neitz S, Magert HJ, Schulz A, Forssmann WG, Schulz-Knappe P, et al. LEAP-1, a novel highly disul- fide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 2000;480:147-50.
62. Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 2001;276:7811- 9.
63. Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn A, et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci USA 2001;98:8780-5.
64. Nemeth E, Roetto A, Garozzo G, Ganz T, Camaschella C. Hepcidin is decreased in TFR2 hemochromatosis. Blood 2005;105:1803-6.
65. Rivera S, Nemeth E, Gabayan V, Lopez MA, Farshidi D, Ganz T. Synthetic hepcidin causes rapid dose- dependent hypoferremia and is concentrated in ferroportin-containing organs. Blood 2005;106:2196-9.
66. Viatte L, Nicolas G, Lou DQ, Bennoun M, Lesbordes-Brion JC, Canonne-Hergaux F, et al. Chronic hepcidin induction causes hypo- sideremia and alters the pattern of cellular iron accumulation in hemo- chromatotic mice. Blood 2006; 107: 2952-8.
67. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004; 113: 1271-6.
68. Nemeth E. Iron regulation and erythropoiesis. Curr Opin Hematol 2008;15:169-75.
69. Babitt JL, Huang FW, Wrighting DM, Xia Y, Sidis Y, Samad TA, et al. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet 2006;38:531-9.
70. Silvestri L, Pagani A, Camaschella C. Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis. Blood 2008;111:924-31.
71. Lin L, Valore EV, Nemeth E, Goodnough JB, Gabayan V, Ganz T. Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4. Blood2007;110:2182-9.
72. Kautz L, Meynard D, Monnier A, Darnaud V Bouvet R, Wang RH, et al. Iron regulates phosphorylation of Smadl/5/8 and gene expression of Bmp6, Smad7, Idl, and Atoh8 in the mouse liver. Blood 2008;112:1503-9.
73. Lee P, Peng H, Gelbart T Wang L, Beutler E. Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc Natl Acad Sci USA 2005;102:1906-10.
74. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 2003; 102:783-8.
75. Tanno T, Bhanu NV, Oneal PA, Goh SH, Staker P, Lee YT, et al. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med 2007;13: 1096-101.
76. Origa R, Galanello R, Ganz T, Giagu N, Maccioni L, Faa G, et al. Liver iron concentrations and urinary hepcidin in P-thalassemia. Haematologica 2007;92:583-8.
77. Lasocki S, Millot S, Andrieu V, Letteron P, Pilard N, Muzeau F, et al. Phlebotomies or erythropoietin injections allow mobilization of iron stores in a mouse model mimicking intensive care anemia. Crit Care Med 2008;36:2388-94.
78. Bessis MC, Jensen WN. Sideroblastic anaemia, mitochondria and erythroblastic iron. Br J Haematol 1965; 11:49- 51.
79. Bottomley SS. Congenital sideroblastic anemias. Curr Hematol Rep 2006; 5:41-9.
80. Camaschella C. Recent advances in the understanding of inherited sideroblastic anaemia. Br J Haematol 2008; 143:27-38.
81. Brownlie A, Donovan A, Pratt SJ, Paw BH, Oates AC, Brugnara C, et al. Positional cloning of the zebrafish sauternes gene: a model for congenital sideroblastic anaemia. Nat Genet 1998;20:244-50.
82. Yamamoto M, Nakajima O. Animal models for X-linked sideroblastic anemia. Int J Hematol 2000;72:157- 64.
83. Nakajima O, Okano S, Harada H, Kusaka T, Gao X, Hosoya T, et al. Transgenic rescue of erythroid 5- aminolevulinate synthase-deficient mice results in the formation of ring sideroblasts and siderocytes. Genes Cells 2006;11:685-700.
84. Cazzola M, Invernizzi R, Bergamaschi G, Levi S, Corsi B, Travaglino E, et al. Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia. Blood 2003;101:1996-2000.
85. Cotter PD, May A, Li L, Al-Sabah Al, Fitzsimons EJ, Cazzola M, et al. Four new mutations in the erythroid-spe- cific 5-aminolevulinate synthase (ALAS2) gene causing X-linked sideroblastic anemia: increased pyridoxine responsiveness after removal of iron overload by phlebotomy and coin-heritance of hereditary hemochromatosis. Blood 1999;93:1757-69.
86. Furuyama K, Fujita H, Nagai T, Yomogida K, Munakata H, Kondo M, et al. Pyridoxine refractory X-linked sideroblastic anemia caused by a point mutation in the erythroid 5- aminolevulinate synthase gene. Blood 1997;90:822-30.
87. Furuyama K, Sassa S. Interaction between succinyl CoA synthetase and the heme-biosynthetic enzyme ALAS-E is disrupted in sideroblastic anemia. J Clin Invest 2000;105:757-64.
88. Allikmets R, Raskind WH, Hutchinson A, Schueck ND, Dean M, Koeller DM. Mutation of a putative mitochondrial iron transporter gene (ABC7) in X-linked sideroblastic ane mia and ataxia (XLSA/A). Hum Mol Genet 1999;8:743-9.
89. Bekri S, Kispal G, Lange H, Fitzsimons E, Tolmie J, Lill R, et al. Human ABC7 transporter: gene structure and mutation causing X-linked sideroblastic anemia with ataxia with disruption of cytosolic iron-sulfur protein maturation. Blood 2000;96:3256-64.
90. Boddaert N, Le Quan Sang KH, Rotig A, Leroy-Willig A, Gallet S, Brunelle F, et al. Selective iron chelation in Friedreich ataxia: biologic and clinical implications. Blood 2007;110:401-8.
91. Wingert RA, Galloway JL, Barut B, Foott H, Fraenkel P, Axe JL, et al. Deficiency of glutaredoxin 5 reveals Fe-S clusters are required for vertebrate haem synthesis. Nature 2005; 436:1035-39.
92. Camaschella C, Campanella A, De Falco L, Boschetto L, Merlini R, Silvestri L, et al. The human counterpart of zebrafish shiraz shows sider- oblastic-like microcytic anemia and iron overload. Blood 2007;110:1353-8.
93. Fleming MD, Trenor CC, 3rd, Su MA, Foernzler D, Beier DR, Dietrich WF, et al. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet 1997;16: 383-6.
94. 94.Fleming MD, Romano MA, Su MA, Garrick LM, Garrick MD, Andrews NC. Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. Proc Natl Acad Sci USA 1998;95:1148- 53.
95. Donovan A, Brownlie A, Dorschner MO, Zhou Y, Pratt SJ, Paw BH, et al. The zebrafish mutant gene chardon- nay (cdy) encodes divalent metal transporter 1 (DMT1). Blood 2002; 100:4655-9.
96. Iolascon A, Camaschella C, Pospisilova D, Piscopo C, Tchernia G, Beaumont C. Natural history of recessive inheritance of DMT1 mutations. J Pediatr 2008;152:136-9.
97. Mims MP, Guan Y, Pospisilova D, Priwitzerova M, Indrak K, Ponka P, et al. Identification of a human mutation of DMT1 in a patient with microcytic anemia and iron overload. Blood 2005;105:1337-42.
98. Lam-Yuk-Tseung S, Mathieu M, Gros P. Functional characterization of the E399D DMT1/NRAMP2/SLC11A2protein produced by an exon 12 mutation in a patient with microcytic anemia and iron overload. Blood Cells Mol Dis 2005;35:212-6.
99. Iolascon A, d'Apolito M, Servedio V, Cimmino F, Piga A, Camaschella C. Microcytic anemia and hepatic iron overload in a child with compound heterozygous mutations in DMT1 (SCL11A2). Blood 2006;107:349-54.
100. Beaumont C, Delaunay J Hetet G, Grandchamp B, de Montalembert M, Tchemia G. Two new human DMT1 gene mutations in a patient with microcytic anemia, low ferritinemia, and liver iron overload. Blood 2006; 107:4168-70.
101. Pospisilova D, Mims MP, Nemeth E, Ganz T, Prchal JT. DMT1 mutation: response of anemia to darbepoetin administration and implications for iron homeostasis. Blood 2006;108: 404-5.
102. Hooper JD, Clements JA, Quigley JP, Antalis TM. Type II transmembrane serine proteases. Insights into an emerging class of cell surface proteolytic enzymes. J Biol Chem 2001; 276:857-60.
103. Du X, She E, Gelbart T, Truksa J, Lee P, Xia Y, et al. The serine protease TMPRSS6 is required to sense iron deficiency. Science 2008;320:1088-92.
104. Finberg KE, Heeney MM, Campagna DR, Aydinok Y, Pearson HA, Hartman KR, et al. Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). Nat Genet 2008;40: 569-71.
105. 105.Melis MA, Cau M, Congiu R, Sole G, Barella S, Cao A, et al. A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron. Haematologica 2008;93: 1473-9.
106. Guillem F, Lawson S, Kannengiesser C, Westerman M, Beaumont C, Grandchamp B. Two nonsense mutations in the TMPRSS6 gene in a patient with microcytic anemia and iron deficiency. Blood 2008;112:2089- 91.
107. 107.Beshara S, Lundqvist H, Sundin J, Lubberink M, Tolmachev V, Valind S, et al. Pharmacokinetics and red cell utilization of iron(III) hydroxide- sucrose complex in anaemic patients: a study using positron emission tomography. Br J Haematol 1999; 104: 296-302.
108. Sassa S. Modern diagnosis and management of the porphyrias. Br J Haematol 2006;135:281-92.
109. Phillips JD, Steensma DP, Pulsipher MA, Spangrude GJ, Kushner JP. Congenital erythropoietic porphyria due to a mutation in GATA1: the first trans-acting mutation causative for a human porphyria. Blood 2007;109: 2618-21.
110. Aizencang G, Solis C, Bishop DF, Warner C, Desnick RJ. Human uro- porphyrinogen-III synthase: genomic organization, alternative promoters, and erythroid-specific expression. Genomics 2000;70:223-31.
111. 111.Solis C, Aizencang GI, Astrin KH, Bishop DF, Desnick RJ. Uroporphyrinogen III synthase erythroid promoter mutations in adjacent GATA1 and CP2 elements cause congenital erythropoietic porphyria. J Clin Invest 2001;107:753-62.
112. 112.Gouya L, Puy H, Robreau AM, Lyoumi S, Lamoril J, Da Silva V, et al. Modulation of penetrance by the wild-type allele in dominantly inherited erythropoietic protoporphyria and acute hepatic porphyrias. Hum Genet 2004;114:256-62.
113. 113.Rademakers LH, Koningsberger JC, Sorber CW, Baart de la Faille H, Van Hattum J, Marx JJ. Accumulation of iron in erythroblasts of patients with erythropoietic protoporphyria. Eur J Clin Invest 1993;23:130-8.
114. Holme SA, Worwood M, Anstey AV, Elder GH, Badminton MN. Erythropoiesis and iron metabolism in dominant erythropoietic protoporphyria. Blood 2007;110:4108-10.
115. 115.Lyoumi S, Abitbol M, Andrieu V, Henin D, Robert E, Schmitt C, et al. Increased plasma transferrin, altered body iron distribution, and microcytic hypochromic anemia in ferro- chelatase-deficient mice. Blood 2007; 109:811-8.
116. Asian D, Crain K, Beutler E. A new case of human atransferrinemia with a previously undescribed mutation in the transferrin gene. Acta Haematol 2007;118:244-7.
117. 117.Beutler E, Gelbart T, Lee P, Trevino R, Fernandez MA, Fairbanks VF. Molecular characterization of a case of atransferrinemia. Blood 2000;96: 4071-4.
118. 118.Trombini P, Coliva T, Nemeth E, Mariani R, Ganz T, Biondi A, et al. Effects of plasma transfusion on hepcidin production in human congenital hypotransferrinemia. Haematologica 2007;92:1407-10.
119. 119.Hayashi A, Wada Y, Suzuki T, Shimizu A. Studies on familial hypotransferrinemia: unique clinical course and molecular pathology. Am J Hum Genet 1993;53:201-13.
120. Harris ZL, Durley AP, Man TK, Gitlin JD. Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. Proc Natl Acad Sci USA 1999;96:10812-7.
121. 121.Vulpe CD, Kuo YM, Murphy TL, Cowley L, Askwith C, Libina N, et al. Hephaestin, a ceruloplasmin homo- logue implicated in intestinal iron transport, is defective in the sla mouse. Nat Genet 1999;21:195-9.
122. Xu X, Pin S, Gathinji M, Fuchs R, Harris ZL. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. Ann N Y Acad Sci 2004;1012:299-305.
123. 123.Kono S, Miyajima H. Molecular and pathological basis of aceruloplasminemia. Biol Res 2006;39:15-23.
124. Laird PW, van der Lugt NM, Clarke A, Domen J, Linders K, McWhir J, et al. In vivo analysis of Pim-1 deficiency. Nucleic Acids Res 1993;21:4750-5.